Holen Sie sich die Stockscreener-App
3.00
1.64%
-0.05
Handel nachbörslich:
2.94
-0.06
-2.00%
Neumora Therapeutics Inc Aktie (NMRA) Neueste Nachrichten
Neumora Therapeutics Inc (NMRA) Sheds More Light on Phase 1b Study of NMRA-511 - Finviz
Esperion Therapeutics Inc (ESPR) Strengthens Business Outlook Amid Strategic Agreements - Bitget
Neumora Therapeutics, Inc. (NASDAQ:NMRA) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
12 Best NASDAQ Penny Stocks to Buy According to Analysts - Insider Monkey
Neumora Therapeutics (NASDAQ:NMRA) Shares Gap DownTime to Sell? - MarketBeat
GSA Capital Partners LLP Cuts Position in Neumora Therapeutics, Inc. $NMRA - MarketBeat
AlphaCore Capital LLC Has $1.16 Million Stock Holdings in Neumora Therapeutics, Inc. $NMRA - MarketBeat
Neumora Therapeutics (NMRA) Projected to Post Earnings on Monday - MarketBeat
Neumora cut to Hold at Stifel after J&J’s VENTURA exit - MSN
Can Neumora Therapeutics Inc. stock withstand economic slowdownJuly 2025 Snapshot & Weekly Setup with High ROI Potential - mfd.ru
Risk Recap: Is Telomir Pharmaceuticals Inc stock a buy or sellFed Meeting & Smart Allocation Stock Tips - baoquankhu1.vn
Neumora Therapeutics CFO Milligan sells $5119 in shares By Investing.com - Investing.com Australia
Neumora Therapeutics CFO Milligan sells $5119 in shares - Investing.com South Africa
Top Neumora Executives Quietly Cash Out in Coordinated Stock Sell-Off - TipRanks
Insider Sell Alert: Michael Milligan Sells Shares of Neumora The - GuruFocus
Neumora Therapeutics (NASDAQ:NMRA) Insider Paul Berns Sells 9,819 Shares - MarketBeat
Insider Selling: Neumora Therapeutics (NASDAQ:NMRA) Insider Sells 6,165 Shares of Stock - MarketBeat
Trading Recap: Will Neumora Therapeutics Inc stock go up in YEARTake Profit & Fast Exit Strategy with Risk Control - baoquankhu1.vn
Neumora Therapeutics advances in novel brain-penetrant therapies - Traders Union
Neumora Therapeutics (NASDAQ:NMRA) Hits New 12-Month High Following Analyst Upgrade - MarketBeat
William Blair upgrades Neumora Therapeutics (NMRA) - MSN
William Blair Upgrades Neumora Therapeutics (NMRA) - Nasdaq
Neumora Therapeutics Stock Jumps, Analyst Sees Upside In Alzheimer's Treatment - Benzinga
Neumora Therapeutics Shares Rise After William Blair Upgrade - marketscreener.com
Neumora Therapeutics (NASDAQ:NMRA) Shares Gap Up After Analyst Upgrade - MarketBeat
William Blair Upgrades Neumora Therapeutics to Outperform From Market Perform - marketscreener.com
Neumora Therapeutics (NASDAQ:NMRA) Rating Increased to Outperform at William Blair - MarketBeat
Will Neumora Therapeutics Inc. stock go up in YEAR2025 Trading Recap & Fast Entry Momentum Trade Alerts - mfd.ru
Neumora Therapeutics Highlights NMRA-511 AD Agitation Signal, Maps Higher-Dose Plan for 2026 - MarketBeat
NMRA Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Neumora Therapeutics (NASDAQ:NMRA) Sets New 1-Year HighHere's What Happened - MarketBeat
Neumora Therapeutics, Inc. (NMRA) Presents at Guggenheim Securities Emerging Outlook: Biotech Summit 2026Slideshow (NASDAQ:NMRA) 2026-02-12 - Seeking Alpha
NMRA: NMRA-511 shows strong efficacy in Alzheimer's agitation; pipeline and cash runway support growth - TradingView
Differentiated NMRA-511 Efficacy and Safety in Alzheimer’s Agitation Support Buy Rating on Neumora - TipRanks
Does Neumora Therapeutics’ (NMRA) Guggenheim Spotlight Recast Its Core Neuroscience Investment Narrative? - simplywall.st
Neumora Therapeutics, Inc. Presents NMRA-511 Efficacy at Biotech Summit - TradingView
Neumora Therapeutics (NASDAQ:NMRA) Trading Up 25.3%What's Next? - MarketBeat
3 Promising Penny Stocks With Market Caps Up To $400M - simplywall.st
Neumora gains after early-stage trial results for Alzheimer’s product - MSN
Neumora Therapeutics, Inc. (NASDAQ:NMRA) Given Average Rating of "Hold" by Analysts - MarketBeat
Resistance Check: Should I buy Neumora Therapeutics Inc stock nowPortfolio Update Report & Expert Verified Movement Alerts - baoquankhu1.vn
Neumora Therapeutics to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026 - The Manila Times
Short Interest in Neumora Therapeutics, Inc. (NASDAQ:NMRA) Drops By 20.2% - MarketBeat
ETF Watch: Will Neumora Therapeutics Inc stock go up in YEAR2025 Earnings Surprises & Consistent Return Investment Signals - baoquankhu1.vn
FY2030 Earnings Estimate for NMRA Issued By HC Wainwright - MarketBeat
Stop Loss: Can QMMM Holdings Limited navigate macro headwindsQuarterly Market Review & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
Investment Review: What makes SZZLU stock attractive todayInflation Watch & Weekly High Return Forecasts - baoquankhu1.vn
NMRA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
Targets Report: Can AZEK continue delivering strong returnsQuarterly Profit Report & AI Based Trade Execution Alerts - baoquankhu1.vn
Volume Report: Is Neumora Therapeutics Inc showing insider buying2025 Fundamental Recap & Weekly Return Optimization Alerts - baoquankhu1.vn
Earnings Beat: Should I hold or sell SPCE nowMarket Weekly Review & Fast Gain Stock Trading Tips - baoquankhu1.vn
RSI Check: Is Neumora Therapeutics Inc benefiting from innovation trends2025 Short Interest & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Aug Wrap: Is Castle Biosciences Inc vulnerable to short sellersVolume Spike & Breakout Confirmation Alerts - baoquankhu1.vn
Why Neumora Therapeutics Inc stock appeals to analystsProduct Launch & Smart Allocation Stock Reports - Bộ Nội Vụ
Neumora Therapeutics (NASDAQ:NMRA) Upgraded at Leerink Partnrs - MarketBeat
3.69%
0.68%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):